Abstract
MBP-1, a cellular factor, appears to be involved in multiple functions, including transcriptional modulation, apoptosis and cell growth regulation. In this study, we have investigated the signaling pathway involved in MBP-1 mediated apoptotic cell death. Human carcinoma cells infected with a replication deficient adenovirus expressing MBP-1 (AdMBP-1) induced apoptosis, when compared with cells infected by replication-defective adenovirus (dl312) as a negative control. Transduction of MBP-1 in carcinoma cells releases cytochrome c from mitochondria into the cytosol leading to activation of procaspase-9, procaspase-3 and PARP cleavage. We previously observed that MBP-1 mediated apoptosis can be protected by Bcl-2, although MBP-1 does not share a homology with the BH domain of the Bcl-2 family member of proteins. To further understand the mechanism of MBP-1 mediated apoptosis, we examined whether MBP-1 modulates the Bcl-2 gene family. Our results demonstrated that human breast carcinoma cells infected with AdMBP-1 selectively reduced Bcl-xL mRNA and protein expression when compared with dl312 infected negative control cells. An in vitro transient reporter assay also suggested repression of the Bcl-x promoter activity by MBP-1. Additional studies indicated that MBP-1 modulates Ets family protein function, thereby downregulating Bcl-xL expression. Taken together, our results suggest that MBP-1 selectively represses Bcl-xL expression in MCF-7 cells and induces mitochondrial involvement in the apoptotic process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ackermann EJ, Taylor JK, Narayana R, Bennett CF . 1999 J. Biol. Chem. 274: 11245–11252
Adams JM, Cory S . 1998 Science 281: 1322–1326
Antonsson B, Martinou JC . 2000 Exp. Cell Res. 256: 50–57
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB . 1993 Cell 74: 597–608
Bossy-Wetzel E, Newmeyer DD, Green DR . 1998 EMBO J. 17: 37–49
Cai J, Yang J, Jones DP . 1998 Biochim. Biophys. Acta. 1366: 139–149
Chaudhury D, Miller DM . 1995 Biochemistry 34: 3438–3445
Chao DT, Korsmeyer SJ . 1998 Annu. Rev. Immunol. 16: 395–419
Chen HM, Boxer LM . 1995 Mol. Cell. Biol. 15: 3840–3847
Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF, Wicha MS . 1996 Cancer Res. 56: 1965–1969
Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A . 2000 FEBS Lett. 473: 47–52
Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poirier GG . 1999 J. Biol. Chem. 274: 28379–28384
Ghosh AK, Steele R, Ray RB . 1999 Mol. Cell. Biol. 19: 2880–2886
Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB . 2000 J. Biol. Chem. 275: 7184–7188
Ghosh AK, Majumder M, Steele R, White RA, Ray RB . 2001 Mol. Cell. Biol. 21: 655–662
Giallongo A, Feo S, Moore R, Croce CM, Showe LC . 1986 Proc. Natl. Acad. Sci. USA 83: 6741–6745
Graham FL . 2000 Immunol. Today 21: 426–428
Green DR, Reed JC . 1998 Science 281: 1309–1312
Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, Nunez Z . 1997 J. Immunol. 158: 4750–4757
Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, Brenner DA . 2000 J. Biol. Chem. 275: 11814–11823
Hu Y, Benedict MA, Wu D, Inohara N, Nunez G . 1998 Proc. Natl. Acad. Sci. USA 95: 4386–4391
Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C, Kufe D . 1997 Proc. Natl. Acad. Sci. USA 94: 6939–6942
Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM . 2000 J. Biol. Chem. 275: 39474–39481
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . 1997 Science 275: 1132–1136
Li F, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ, Fritz LC . 1997 J. Biol. Chem. 272: 30299–30305
Liu R, Page C, Beidler DR, Wicha MS, Nunez G . 1999a Am. J. Pathol. 155: 1861–1867
Liu T-J, El-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL . 1995 Cancer Res. 55: 3117–3122
Liu T-J, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL . 1999b Cancer Gene Ther. 6: 163–172
Liu X, Kim CN, Yang J, Jemmerson R, Wang X . 1996 Cell 86: 147–157
Mercatante DR, Bortner CD, Cidlowski JA, Kole R . 2001 J. Biol. Chem. 276: 16411–16417
Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB, Recant WM . 1997 Cancer J. Sci. Am. 3: 230–237
Ray RB . 1995 Cell Growth Differ. 6: 1089–1096
Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R . 1998 J. Biol. Chem. 273: 2256–2259
Ray R, Miller DM . 1991 Mol. Cell. Biol. 11: 2154–2161
Ray RB, Sheikh MS, Fontana JF, Miller DM . 1994 Int. J. Oncol. 5: 1433–1436
Ray RB, Steele R, Seftor E, Hendrix M . 1995 Cancer Res. 55: 3747–3751
Ray R, Thomas S, Miller DM . 1989 Oncogene 4: 593–600
Reed JC . 1997 Cell 91: 559–562
Reed JC . 1998 Cancer J. Sci. Am. 4: S8–S14
Reed JC . 1999 J. Clin. Oncol. 17: 2941–2953
Reed JC, Jurgensmeier JM, Matsuyama S . 1998 Biochim. Biophys. Acta 1366: 127–137
Reeve JG, Xiong J, Morgan J, Bleehen NM . 1996 Br. J. Cancer 73: 1193–1200
Schmitt E, Cimoli G, Steyaert A, Bertrand R . 1998 Exp. Cell Res. 240: 107–121
Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O, Pognonec P, Boulukos KE . 1999 Mol. Cell. Biol. 19: 2624–2634
Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y . 1996 Oncogene 13: 21–29
Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR . 1992 Science 257: 212–214
Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang H-G, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ . 1999 J. Cell Biol. 144: 281–292
Steller H . 1995 Science 267: 1445–1449
Strasser A, O'Connor L, Dixit VM . 2000 Annu. Rev. Biochem. 69: 217–245
Subramaniun A, Miller DM . 2000 J. Biol. Chem. 275: 5958–5965
Susin SA, Zamzami N, Kroemer G . 1998 Biochim. Biophys. Acta 1366: 151–165
Thompson CB . 1995 Science 267: 1456–1462
Thornberry NA, Lazebnik Y . 1998 Science 281: 1312–1326
Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A . 1998 Cancer Res. 58: 256–262
White RA, Adkison LR, Dowler LL, Ray RB . 1997 Genomics 39: 406–408
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X . 1997 Science 275: 1129–1132
Yasushi F, Keita K, Hisao H, Keiko Y-T, Tadamitsu K . 1997 J. Clin. Invest. 99: 2898–2905
Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G . 1998 Oncogene 16: 2265–2282
Acknowledgements
This research was supported by grant CA52799 from the National Cancer Institute. We thank Linda Boxer, G Chinnadurai and Ranjan Sen for helpful suggestions. Authors thank G Chinnadurai for providing Bcl-2 antibody, Keiko Yamauchi-Takihara for providing Bcl-x promoter constructs, and Maria Trojanowska for providing synthetic Ets-TK construct and Ets-1 cDNA for our research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghosh, A., Majumder, M., Steele, R. et al. MBP-1 mediated apoptosis involves cytochrome c release from mitochondria. Oncogene 21, 2775–2784 (2002). https://doi.org/10.1038/sj.onc.1205384
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205384
Keywords
This article is cited by
-
Proteomic analysis of differentially expressed proteins in 5-fluorouracil-treated human breast cancer MCF-7 cells
Clinical and Translational Oncology (2014)
-
Hypoxia induces differential translation of enolase/MBP-1
BMC Cancer (2010)